Expression Level of Wnt5a Was Related to the Therapeutic Effects of First-Generation EGFR-TKIs.

Hai ZhangXiaohua YangFang HuChanghui LiJianlin XuWei NieYinchen ShenYuqing LouBaohui HanHua ZhongXueyan Zhang

Published in: OncoTargets and therapy (2020)

The expression level of Wnt5a was found to be associated with therapeutic effects of first-generation EGFR-TKIs in lung adenocarcinoma patients harboring sensitive EGFR mutations.

Keyphrases

small cell lung cancer
epidermal growth factor receptor
tyrosine kinase
poor prognosis
end stage renal disease
stem cells
cell proliferation
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
binding protein
patient reported outcomes